Ardelyx Inc (ARDX): Next-Year EPS Estimate 1004.34%
As of 2026-06-04, Ardelyx Inc (ARDX) has a next-year EPS growth estimate of 1004.34%.
On 2026-05-03, analyst consensus for ARDX's next-year EPS growth shifted from 10057.14% to 1004.34% — a negative change of 9052.80 percentage points. The revised estimate has been sustained across 25 subsequent trading sessions. Current-year growth is projected at 80.20%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 1004.34%
- EPS growth this year
- 80.20%
- EPS next quarter (est)
- -$0.03
- Last price
- $5.40
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 1004.34% | 80.20% | -$0.03 | $5.40 |
| 2026-06-03 | 1004.34% | 80.20% | -$0.03 | $5.42 |
| 2026-06-02 | 1004.34% | 80.20% | -$0.03 | $5.52 |
| 2026-06-01 | 1004.34% | 80.20% | -$0.03 | $5.73 |
| 2026-05-31 | 1004.34% | 80.20% | -$0.03 | $6.04 |
| 2026-05-28 | 1004.34% | 80.20% | -$0.03 | $6.25 |
| 2026-05-27 | 1004.34% | 80.20% | -$0.03 | $6.17 |
| 2026-05-26 | 1004.34% | 80.20% | -$0.03 | $6.25 |
| 2026-05-25 | 1004.34% | 80.20% | -$0.03 | $6.11 |
| 2026-05-24 | 1004.34% | 80.20% | -$0.03 | $6.11 |
| 2026-05-21 | 1004.34% | 80.20% | -$0.03 | $6.35 |
| 2026-05-20 | 1004.34% | 80.20% | -$0.03 | $6.27 |
| 2026-05-19 | 1004.34% | 80.20% | -$0.03 | $6.09 |
| 2026-05-18 | 1004.34% | 80.20% | -$0.03 | $6.11 |
| 2026-05-17 | 1004.34% | 80.20% | -$0.03 | $6.23 |
| 2026-05-14 | 1004.34% | 80.20% | -$0.03 | $6.46 |
| 2026-05-13 | 1004.34% | 80.20% | -$0.03 | $6.38 |
| 2026-05-12 | 1004.34% | 80.20% | -$0.03 | $6.61 |
| 2026-05-11 | 1004.34% | 80.20% | -$0.03 | $6.61 |
| 2026-05-10 | 1004.34% | 80.20% | -$0.03 | $6.78 |
| 2026-05-07 | 1004.34% | 80.20% | -$0.03 | $6.98 |
| 2026-05-06 | 1004.34% | 80.20% | -$0.03 | $7.10 |
| 2026-05-05 | 1004.34% | 80.20% | -$0.03 | $7.13 |
| 2026-05-04 | 1004.34% | 80.20% | -$0.03 | $7.30 |
| 2026-05-03 | 1004.34% | 80.20% | -$0.03 | $6.88 |
| 2026-04-30 | 10057.14% | 101.88% | -$0.14 | $6.33 |
| 2026-04-29 | 10057.14% | 101.88% | -$0.14 | $6.01 |
| 2026-04-28 | 3124.71% | 106.11% | -$0.14 | $5.97 |
| 2026-04-27 | 3124.71% | 106.11% | -$0.14 | $5.99 |
| 2026-04-26 | 3124.71% | 106.11% | -$0.14 | $5.95 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Ardelyx Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Ardelyx Inc (ARDX) has a next-year EPS growth estimate of 1004.34%, based on analyst consensus.
When was the latest EPS estimate revision for ARDX?▾
The most recent revision occurred on 2026-05-03, when analysts adjusted the next-year EPS growth estimate from 10057.14% to 1004.34%.
What sector and industry does Ardelyx Inc belong to?▾
Ardelyx Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ARDX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Ardelyx Inc (ARDX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports